Anaphylaxis with Intravenous Antibiotics

Clinical Presentation

Anaphylaxis with IV antibiotics may present with hypotension, tachycardia or bradycardia, cutaneous manifestations, bronchospasm, angioedema, and cardiovascular collapse in patients who have previously tolerated the antibiotic, with hypotension being the sole clinical feature in approximately 10% of patients, and bradycardia seen in approximately 10% of patients with allergic anaphylaxis during anesthesia 1
Symptoms of anaphylaxis typically develop rapidly (within minutes to 2 hours) and may include hypotension, tachycardia, cutaneous manifestations, respiratory symptoms, and gastrointestinal symptoms 1
Hypotension may be the sole clinical feature in approximately 10% of patients, and the absence of cutaneous signs does not exclude anaphylaxis 2, 1

Patients with asthma or atopic conditions have an increased risk of anaphylaxis 3, 1
Patients on beta-blockers may experience more severe reactions 3
Patients with severe forms of rheumatic heart disease appear to have a higher risk of anaphylaxis, as reported by the Clinical Reviews in Allergy and Immunology 2
The incidence of anaphylaxis to parenteral penicillins occurs at a rate of approximately 1 in 123,792 exposures, as stated by the Clinical Reviews in Allergy and Immunology 2

Beta-lactam antibiotics (penicillins, cephalosporins) pose a higher risk of anaphylaxis 1, 3
Cephalosporins have a lower risk of anaphylaxis than penicillins, but still pose a significant risk, with cross-reactivity with penicillins occurring in approximately 4% of patients with confirmed penicillin allergy 3
Carbapenems should be considered cross-reactive with penicillin 3
Monobactams, such as Aztreonam, are generally safe in penicillin-allergic patients, except when cross-reactivity with ceftazidime exists 3
Fluoroquinolones can cause both IgE-mediated and non-IgE-mediated reactions (1-5 per 100,000 prescriptions) 4, 5
Macrolides have a lower risk of allergic reactions compared to other antibiotic classes 4

Epinephrine is the first-line treatment for anaphylaxis 1
Immediate discontinuation of the antibiotic is recommended in cases of anaphylaxis
Test doses are not reliable for predicting anaphylaxis as they would require serial challenges with increasing doses starting with minuscule amounts, according to Anaesthesia 1

Complete avoidance of the implicated antibiotic is generally recommended for patients who have experienced anaphylaxis to IV antibiotics
Ciprofloxacin is an appropriate alternative antibiotic for patients with amoxicillin allergy, particularly for respiratory fluoroquinolone-sensitive infections, as recommended by the Centers for Disease Control and Prevention 6 and the Infectious Diseases Society of America 7
Respiratory fluoroquinolones (including ciprofloxacin) are recommended as alternatives for patients with penicillin allergy for community-acquired pneumonia, according to the Centers for Disease Control and Prevention 6 and the Infectious Diseases Society of America 7
Doxycycline is another alternative option for sinusitis, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 8
First-generation cephalosporins, clindamycin, clarithromycin, or azithromycin are preferred alternatives for Group A streptococcal pharyngitis, according to the American Academy of Family Physicians 9
Ciprofloxacin plus metronidazole is listed as a second-choice option for intra-abdominal infections by the European Society of Clinical Microbiology and Infectious Diseases 10

Fluoroquinolones should be used with caution in patients where TB is suspected but not being treated with standard TB therapy, as recommended by the Centers for Disease Control and Prevention 6
Due to resistance concerns and adverse effects, fluoroquinolones should be reserved for situations where truly needed, according to the Centers for Disease Control and Prevention 6 and the Infectious Diseases Society of America 7
Most reported penicillin allergies (approximately 95%) are not true allergies, as noted by the American Academy of Allergy, Asthma, and Immunology, although this fact is reported by Praxis Medical Insights 11
Inadequate documentation of allergy labels often lacks critical information needed to assess true risk, and proper documentation should include reaction details, timing, and management 5